Home β€Ί Stock analysis β€Ί TNON

Tenon Medical (TNON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

TNON slides 7.2% to $2.70, a 1-month low. Closed at $2.70, -7.22% vs the prior close of $2.91. Day range $2.67–$3.05, opened at $2.95.

Last close$2.70-7.22%
Day range2.67–3.05
Open2.95
Volume210.69K
52-week range2.40–50.40
Avg volume (20d)3.38M

TNON daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” TNON slides 7.2% to $2.70, a 1-month low
Oct 15, 2026 β€” TNON jumps 3.2% to $2.91
Oct 14, 2026 β€” TNON dips 2.4% to $2.82, 6 down days in a row
Oct 13, 2026 β€” TNON slides 3.0% to $2.89, 5 down days in a row
Oct 12, 2026 β€” TNON slides 12.6% to $2.98, 4 down days in a row
Oct 9, 2026 β€” TNON dips 0.9% to $3.41, 3 down days in a row
Oct 8, 2026 β€” TNON dips 1.7% to $3.44
Oct 7, 2026 β€” TNON slides 5.8% to $3.50
Oct 6, 2026 β€” TNON rises 0.4% to $3.71
Oct 5, 2026 β€” TNON ends flat (+0.0%) to $3.70, 3 down days in a row
Oct 2, 2026 β€” TNON slides 8.4% to $3.70

TNON latest news & SEC filings

Every SEC filing by or about TNON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 16, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-110252

Oct 9, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-003214

Oct 9, 2026 Β· Form 424B3 β€” Prospectus / supplement for an offering or resale

Prospectus / supplement for an offering or resale

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-108484

Oct 9, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001213900-26-108458

Oct 5, 2026 Β· Form S-3 β€” Shelf registration (S-3)

Shelf registration (S-3) β€” lets the company sell securities over time

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-106579

Sep 21, 2026 Β· Form D β€” D filing

D filing

Source: SEC EDGAR filing 0001213900-26-101515

Sep 16, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-100596

Sep 11, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001475597-26-000240

Sep 10, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001213900-26-098774

Sep 9, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-098232

Sep 8, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001475597-26-000234

Sep 8, 2026 Β· Form 424B3 β€” Prospectus / supplement for an offering or resale

Prospectus / supplement for an offering or resale

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-097777

Sep 4, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002889

Sep 4, 2026 Β· Form D β€” D filing

D filing

Source: SEC EDGAR filing 0001213900-26-097552

Sep 3, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001475597-26-000230

Things to know before you trade TNON

TNON market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20262.953.052.672.70210.69K
Oct 15, 20262.832.932.782.91149.90K
Oct 14, 20262.822.942.802.82157.10K
Oct 13, 20262.983.102.852.89225.90K
Oct 12, 20263.343.362.952.98262.70K
Oct 9, 20263.413.523.373.41129.90K
Oct 8, 20263.463.583.423.44111.10K
Oct 7, 20263.583.643.383.50355.00K
Oct 6, 20263.803.823.623.71422.70K
Oct 5, 20263.553.823.523.70455.00K
Oct 2, 20264.504.653.653.705.89M
Oct 1, 20263.944.183.654.042.09M
Sep 30, 20262.805.042.754.0953.28M
Sep 29, 20262.802.882.672.73279.00K
Sep 28, 20263.033.052.862.86191.00K
Sep 25, 20262.953.182.943.131.73M
Sep 24, 20263.183.272.952.96360.20K
Sep 23, 20263.363.423.253.27210.10K
Sep 22, 20263.633.663.413.43560.80K
Sep 21, 20264.044.083.703.73518.80K

About Tenon Medical

Tenon Medical (TNON) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in LOS GATOS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1560293.

TNON board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Steven M FosterCEO and PresidentAug 4, 2026
Richard FerrariDirectorAug 4, 2026
Richard GinnChief Technology OfficerAug 4, 2026
Ivan HowardDirectorAug 4, 2026
Stephen HochschulerDirectorAug 4, 2026
Kristine M JacquesDirectorAug 4, 2026
Robert K WeigleDirectorAug 4, 2026

Executive officers

NameTitleLatest filing
Steven M FosterCEO and PresidentAug 4, 2026
Richard GinnChief Technology OfficerAug 4, 2026
Wyatt D. GeistChief Innovation OfficerMay 5, 2026
Nathaniel A. GraweyChief Commercial OfficerMay 5, 2026
Kevin WilliamsonChief Financial OfficerSep 10, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 10, 2026Financial Lp HrtSale65,582$5.56
Sep 10, 2026Financial Lp HrtBuy8,431$4.92
Sep 10, 2026Financial Lp HrtBuy28,267$4.02
Sep 10, 2026Financial Lp HrtBuy31,227$2.92
Sep 10, 2026Financial Lp HrtSale65,582$5.56
Sep 10, 2026Financial Lp HrtBuy8,431$4.92
Sep 10, 2026Financial Lp HrtBuy28,267$4.02
Sep 10, 2026Financial Lp HrtBuy31,227$2.92
Sep 10, 2026Financial Lp HrtSale65,582$5.56
Sep 10, 2026Financial Lp HrtBuy8,431$4.92
Sep 10, 2026Financial Lp HrtBuy28,267$4.02
Sep 10, 2026Financial Lp HrtBuy31,227$2.92
Sep 10, 2026Financial Lp HrtSale65,582$5.56
Sep 10, 2026Financial Lp HrtBuy8,431$4.92
Sep 10, 2026Financial Lp HrtBuy28,267$4.02

TNON financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$3.94M$-12.56M-1.70$-10.74M
Dec 31, 2024$3.28M$-13.67M-11.26$-9.88M
Dec 31, 2023$2.93M$-15.58M-68.64$-12.18M
Dec 31, 2022$691.00K$-18.92M-23.62$-12.03M
Dec 31, 2021$160.00K$-7.05M-7.81$-4.29M

Latest balance sheet: total assets $9.92M, total liabilities $11.66M, cash $1.68M (as of Jun 30, 2026).

TNON earnings / results-day log

DateFilingClose that day
Aug 13, 20268-K Item 2.02 (results)$5.96
May 12, 20268-K Item 2.02 (results)$28.49
Mar 19, 20268-K Item 2.02 (results)$29.23
Feb 6, 20268-K Item 2.02 (results)$23.49
Mar 14, 20248-K Item 2.02 (results)β€”
Jun 7, 20228-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on TNON

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.